Strides Pharma Science Limited's formulations facility in Alathur, India which was inspected by the USFDA in August 2019 has received the Establishment Inspection Report (EIR), there by confirming the successful closure of the inspections. The inspection conducted in August 2019 had concluded with Zero 483 observations. The facility has recently completed a significant capacity expansion and will support the growth momentum for the US business.
Shares of Strides Pharma Science Ltd was last trading in BSE at Rs.350.25 as compared to the previous close of Rs. 353.8. The total number of shares traded during the day was 34012 in over 576 trades.
The stock hit an intraday high of Rs. 358.2 and intraday low of 348.75. The net turnover during the day was Rs. 11974044.